Harrow Health sells part of company for up to $10.5 million


Harrow Health will now exclusively be an eye care pharmaceutical company focused on the discovery, development and commercialization of eye care therapies.

Previous What the strong dollar means for trade between the UK, North Carolina
Next Oishei Children's Hospital leader to depart for Fla. role